N-acetylcysteine in the prevention of contrast-induced nephropathy. To administer or not to administer: That is the question;N-acetilcisteína en la prevención de la nefropatía inducida por contraste. Administrar o no administrar: Ésta es la cuestión

Revista Espanola de Cardiologia

Volumn 63, Issue 1, 2010, Pages 9-11

  Mehran, Roxana ^a   Caixeta, Adriano ^a  

^a Fundación de Investigación Cardiovascular ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CREATININE; PLACEBO; CONTRAST MEDIUM;

CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; EDITORIAL; GLOMERULUS FILTRATION; HUMAN; KIDNEY FUNCTION; PERCUTANEOUS CORONARY INTERVENTION; PROPHYLAXIS; CHEMICALLY INDUCED DISORDER; KIDNEY DISEASE; NOTE;

ACETYLCYSTEINE; CONTRAST MEDIA; HUMANS; KIDNEY DISEASES;

EID: 77349103438     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(10)70003-8     Document Type: Editorial

References (15)

1. W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 117 2008 e25 146
2. S. Cook, A. Walker, O. Hugli, M. Togni, and B. Meier Percutaneous coronary interventions in Europe: prevalence, numerical estimates, and projections based on data up to 2004 Clin Res Cardiol 96 2007 375 382 (Pubitemid 46798974)
3. R. Solomon, and G. Deray How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations Kidney Int Suppl 2006 S51 S53
4. K. Nash, A. Hafeez, and S. Hou Hospital-acquired renal insufficiency Am J Kidney Dis 39 2002 930 936 (Pubitemid 34454211)
5. C.S. Rihal, S.C. Textor, D.E. Grill, P.B. Berger, H.H. Ting, P.J. Best, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 105 2002 2259 2264
6. R. Mehran, E.D. Aymong, E. Nikolsky, Z. Lasic, I. Iakovou, and M. Fahy A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 2004 1393 1399 (Pubitemid 39303939)
7. A. Caixeta, E. Nikolsky, and R. Mehran Prevention and treatment of contrast-associated nephropathy in interventional cardiology Curr Cardiol Rep 11 2009 377 383
8. J.G. Webb, G.E. Pate, K.H. Humphries, C.E. Buller, S. Shalansky, and A. Al Shamari A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrastinduced nephropathy after cardiac catheterization: lack of effect Am Heart J 148 2004 422 429 (Pubitemid 39265114)
9. N. Pannu, B. Manns, H. Lee, and M. Tonelli Systematic review of the impact of N-acetylcysteine on contrast nephropathy Kidney Int 65 2004 1366 1374 (Pubitemid 38406975)
10. A.M. Kelly, B. Dwamena, P. Cronin, S.J. Bernstein, and R.C. Carlos Meta-analysis: effectiveness of drugs for preventing contrastinduced nephropathy Ann Intern Med 148 2008 284 294 (Pubitemid 351665489)
11. H. Trivedi, S. Daram, A. Szabo, A.L. Bartorelli, and G. Marenzi Highdose N-acetylcysteine for the prevention of contrast-induced nephropathy Am J Med 122 2009 874 e879-15
12. N. Carbonell, R. Sanjuán, M. Blasco, A. Jordá, and A. Miguel N-acetilcisteína: beneficio clínico a corto plazo tras coronariografía en pacientes renales de alto riesgo Rev Esp Cardiol 63 2010 12 19
13. C.S. Baker, A. Wragg, S. Kumar, R. De Palma, L.R. Baker, and C.J. Knight A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study J Am Coll Cardiol 41 2003 2114 2118 (Pubitemid 36724254)
14. G. Marenzi, E. Assanelli, I. Marana, G. Lauri, J. Campodonico, and M. Grazi N-acetylcysteine and contrast-induced nephropathy in primary angioplasty N Engl J Med 354 2006 2773 2782 (Pubitemid 43974195)
15. U. Hoffmann, M. Fischereder, B. Kruger, W. Drobnik, and B.K. Kramer The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable J Am Soc Nephrol 15 2004 407 410 (Pubitemid 38140781)